Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Aerie Pharmaceuticals (NQ: AERI)
20.51 USD  -0.74 (-3.48%)
Official Closing Price  /  Updated: 4:49 PM EDT, Oct 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,616,000
Open 21.02
Bid (Size) 18.00 (1)
Ask (Size) 23.31 (1)
Prev. Close 21.25
Today's Range 19.97 - 21.42
52wk Range 17.51 - 60.05
Shares Outstanding 39,496,520
Dividend Yield N/A
Performance
YTD
-43.53%
-43.53%
1 Month
-5.22%
-5.22%
3 Month
-11.29%
-11.29%
6 Month
-46.45%
-46.45%
1 Year
-64.79%
-64.79%
Top News
More News
Aerie Pharmaceuticals Announces Appointment of Charlene E. Davis, Esq., as Vice President and Chief Compliance Officer
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... Read More
from Business Wire News Releases
Aerie Pharmaceuticals to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... Read More
from Business Wire News Releases
More News
Read More
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa® in the European Union
from Business Wire News Releases
Aerie Pharmaceuticals Submits Prior Approval Supplement to the U.S. Food and Drug Administration to Allow Production of Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in its
from Business Wire News Releases
Aerie Pharmaceuticals Announces Full Exercise by Initial Purchasers of Option to Purchase Additional $41.25 Million Aggregate Principal Amount of Aerie’s 1.50% Convertible Senior Notes Due 2024
from Business Wire News Releases
IWO's Holdings Imply 29% Gain Potential
category ETFs
from ETF Channel
Here's Why Aerie Pharmaceuticals Rose as Much as 21.8% Today
category AERI , Market News
from Motley Fool
Insiders Now Seeing Red With AERI At New 52-Week Low
category Stocks
from Market News Video
Aerie Pharmaceuticals Upsizes and Prices Private Offering of $275 Million 1.50% Convertible Senior Notes Due 2024
from Business Wire News Releases
Tuesday 9/10 Insider Buying Report: AERI, NKTR
category Stocks
from Market News Video
Top Buys by Top Brass: Chief Executive Officer Anido Jr.'s $499K Bet on AERI
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.